Skip to main content
. 2023 Dec 28;32(3):101942. doi: 10.1016/j.jsps.2023.101942

Fig. 2.

Fig. 2

Comprehensive examination of TAOK3 phosphorylation in various cancer types. The UALCAN platform was utilised to analyse the expression level of the TAOK3 phosphoprotein in selected cancers, comparing it between normal tissue and primary tumour, based on data from the CPTAC dataset. (A) Diagram of TAOK3 phosphorylation sites. (B-D) The box plots representing various types of malignancies are presented. (E) The Impact of TAOK3 Phosphorylation on the Pathological Grade of Various Tumours.